ArticleNeuro-oncology2023

Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.

Philipp Karschnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.